Literature DB >> 33513317

Trimethoprim-Sulfamethoxazole-associated Fulminant Respiratory Failure in Children and Young Adults.

Jenna O Miller1, Angela R Shih2, Mari Mino-Kenudson2, Martin S Taylor2, Jennifer L Goldman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33513317      PMCID： PMC8017575          DOI： 10.1164/rccm.202009-3421LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  11 in total

1.  Delayed Alveolar Epithelialization: A Distinct Pathology in Diffuse Acute Lung Injury.

Authors:  Martin S Taylor; Raghu R Chivukula; Laura C Myers; William R Jeck; Purushothama R Tata; Walter J O'Donnell; Carol F Farver; B Taylor Thompson; Jayaraj Rajagopal; Richard L Kradin
Journal:  Am J Respir Crit Care Med       Date:  2018-02-15       Impact factor: 21.405

2.  Interstitial lung disease during trimethoprim/sulfamethoxazole administration.

Authors:  Syota Yuzurio; Naokatsu Horita; Yutaro Shiota; Arihiko Kanehiro; Mitsune Tanimoto
Journal:  Acta Med Okayama       Date:  2010-06       Impact factor: 0.892

3.  Persistent Pathology in Influenza-Infected Mouse Lungs.

Authors:  Cindy M Kanegai; Ying Xi; Matthew L Donne; Jeffrey E Gotts; Ian H Driver; Gorica Amidzic; Andrew J Lechner; Kirk D Jones; Andrew E Vaughan; Harold A Chapman; Jason R Rock
Journal:  Am J Respir Cell Mol Biol       Date:  2016-10       Impact factor: 6.914

4.  Pathology of Vaping-Associated Lung Injury.

Authors:  Yasmeen M Butt; Maxwell L Smith; Henry D Tazelaar; Laszlo T Vaszar; Karen L Swanson; Matthew J Cecchini; Jennifer M Boland; Melanie C Bois; James H Boyum; Adam T Froemming; Andras Khoor; Isabel Mira-Avendano; Aiyub Patel; Brandon T Larsen
Journal:  N Engl J Med       Date:  2019-10-02       Impact factor: 91.245

5.  Severe Acute Respiratory Failure in Healthy Adolescents Exposed to Trimethoprim-Sulfamethoxazole.

Authors:  Jenna O Miller; Jane Taylor; Jennifer L Goldman
Journal:  Pediatrics       Date:  2019-06       Impact factor: 7.124

6.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

7.  Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.

Authors:  Maximilian Ackermann; Stijn E Verleden; Mark Kuehnel; Axel Haverich; Tobias Welte; Florian Laenger; Arno Vanstapel; Christopher Werlein; Helge Stark; Alexandar Tzankov; William W Li; Vincent W Li; Steven J Mentzer; Danny Jonigk
Journal:  N Engl J Med       Date:  2020-05-21       Impact factor: 91.245

8.  Acute eosinophilic pneumonia: histopathologic findings in nine patients.

Authors:  H D Tazelaar; L J Linz; T V Colby; J L Myers; A H Limper
Journal:  Am J Respir Crit Care Med       Date:  1997-01       Impact factor: 21.405

9.  The role of open-lung biopsy in ARDS.

Authors:  Sanjay R Patel; Dimitri Karmpaliotis; Najib T Ayas; Eugene J Mark; John Wain; B Taylor Thompson; Atul Malhotra
Journal:  Chest       Date:  2004-01       Impact factor: 9.410

10.  A Conserved Distal Lung Regenerative Pathway in Acute Lung Injury.

Authors:  Martin S Taylor; Raghu R Chivukula; Laura C Myers; William R Jeck; Avinash Waghray; Purushothama R Tata; Martin K Selig; Walter J O'Donnell; Carol F Farver; B Taylor Thompson; Jayaraj Rajagopal; Richard L Kradin
Journal:  Am J Pathol       Date:  2018-02-21       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.